Jane Street’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.67M | Buy |
+16,500
| New | +$1.71M | ﹤0.01% | 5507 |
|
|
2025
Q4 | – | Sell |
-4,900
| Closed | -$622K | – | 11412 |
|
|
2025
Q3 | $622K | Sell |
4,900
-21,700
| -82% | -$2.58M | ﹤0.01% | 7371 |
|
|
2025
Q2 | $3.26M | Buy |
26,600
+14,100
| +113% | +$1.61M | ﹤0.01% | 3634 |
|
|
2025
Q1 | $1.27M | Buy |
+12,500
| New | +$1.22M | ﹤0.01% | 5134 |
|
|
2024
Q4 | – | Sell |
-29,200
| Closed | -$2.82M | – | 9663 |
|
|
2024
Q3 | $2.82M | Sell |
29,200
-10,900
| -27% | -$980K | ﹤0.01% | 3839 |
|
|
2024
Q2 | $3.44M | Sell |
40,100
-20,700
| -34% | -$1.74M | ﹤0.01% | 3572 |
|
|
2024
Q1 | $5.02M | Buy |
60,800
+42,800
| +238% | +$3.13M | ﹤0.01% | 2600 |
|
|
2023
Q4 | $1.2M | Buy |
18,000
+14,800
| +463% | +$959K | ﹤0.01% | 5234 |
|
|
2023
Q3 | $215K | Sell |
3,200
-8,800
| -73% | -$605K | ﹤0.01% | 7521 |
|
|
2023
Q2 | $813K | Sell |
12,000
-105,800
| -90% | -$6.63M | ﹤0.01% | 5552 |
|
|
2023
Q1 | $6.37M | Buy |
117,800
+13,900
| +13% | +$809K | ﹤0.01% | 2123 |
|
|
2022
Q4 | $6.21M | Buy |
103,900
+98,000
| +1,661% | +$5.33M | ﹤0.01% | 2196 |
|
|
2022
Q3 | $267K | Sell |
5,900
-24,017
| -80% | -$1.2M | ﹤0.01% | 7762 |
|
|
2022
Q2 | $1.33M | Sell |
29,917
-66,746
| -69% | -$3.42M | ﹤0.01% | 4945 |
|
|
2022
Q1 | $5.47M | Buy |
96,663
+15,461
| +19% | +$807K | ﹤0.01% | 2889 |
|
|
2021
Q4 | $4.22M | Sell |
81,202
-52,543
| -39% | -$2.71M | ﹤0.01% | 3117 |
|
|
2021
Q3 | $7.98M | Buy |
133,745
+107,348
| +407% | +$6.75M | ﹤0.01% | 2097 |
|
|
2021
Q2 | $1.64M | Buy |
26,397
+2,388
| +10% | +$159K | ﹤0.01% | 4747 |
|
|
2021
Q1 | $1.56M | Sell |
24,009
-7,039
| -23% | -$459K | ﹤0.01% | 4503 |
|
|
2020
Q4 | $2.04M | Sell |
31,048
-131,608
| -81% | -$7.74M | ﹤0.01% | 3448 |
|
|
2020
Q3 | $8.41M | Buy |
162,656
+146,315
| +895% | +$7.51M | 0.01% | 1362 |
|
|
2020
Q2 | $805K | Buy |
+16,341
| New | +$882K | ﹤0.01% | 4389 |
|
|
2017
Q2 | – | Sell |
-6,159
| Closed | -$210K | – | 4441 |
|
|
2017
Q1 | $210K | Sell |
6,159
-5,531
| -47% | -$182K | ﹤0.01% | 3815 |
|
|
2016
Q4 | $384K | Buy |
+11,690
| New | +$379K | ﹤0.01% | 3109 |
|
|
2016
Q3 | – | Sell |
-14,330
| Closed | -$443K | – | 4100 |
|
|
2016
Q2 | $443K | Buy |
+14,330
| New | +$448K | ﹤0.01% | 2891 |
|
Other funds holding EHC
Jane Street's EHC Position: Q2 2026 in Review
Jane Street increased its Encompass Health (EHC) stake by 13,576% in Q2 2026, buying an estimated $59.9M and bringing the position to 582,596 shares worth $58.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1284.
Jane Street first reported a position in EHC in Q1 2017 and has held it in 35 quarters since. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- Jane Street held 582,596 shares of Encompass Health worth $58.9M as of Q2 2026.
- Jane Street bought 578,336 Encompass Health shares in Q2 2026, an estimated $59.9M.
- Encompass Health made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1284 holding.
- Jane Street first reported a position in Encompass Health in Q1 2017 and has held it in 35 quarters since.
- 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.